GI Innovation

GI Innovation is a bio-venture company that researches and develops innovative protein new drugs through well-structured translational research. The primary research and development for GI Innovation is immuno-oncology drug and allergy disease and developing a fusion protein using the GI-SMART™ platform. Currently, research and development is underway on subsequent pipelines such as non-alcoholic fatty hepatitis (NASH), following immuno-oncology drug and allergy treatments that continue to be researched and developed. We, GI Innovation, will do our best to advance treatments for patients with incurable diseases around the world.